Systems Biology and Animal Models: STRIDE

Similar documents
Synthetic Genomics and Its Application to Viral Infectious Diseases. Timothy Stockwell (JCVI) David Wentworth (JCVI)

Product Development for Public Health & Emerging Infections

APHL Next Generation Sequencing (NGS) Survey

UNRAVELING THE MYSTERY BEHIND HIV/AIDS

Centers for Disease Control and Prevention (CDC) FY 2009 Budget Request Summary

PIP Framework Information Session 10 April 2018

Planning, Priority Setting, and Budget Development for NIH AIDS Research

Evolution of influenza

National Vaccine Plan Goal 4 Immunization Information Systems. Mike Garcia Scientific Technologies Corporation 24 July 2008

Health Task Force Workplan

HIV/AIDS Research Portfolio Review Working Groups Submits Science Priorities Report to NIH Director

NIH HEAL Initiative: Program Update and Funding Opportunities for Pain Research Available through NIH

Vaccines: Reaching for higher branches after the low hanging fruit has been picked

Nanoparticulate Vaccine Design: The VesiVax System


RITM Laboratory Response During the 2009 Influenza H1N1 Pandemic

Blueprint for R&D preparedness and response to public health emergencies due to highly infectious pathogens WORKSHOP ON PRIORITIZATION OF PATHOGENS

Global Pandemic Preparedness Research Efforts. Klaus Stöhr. WHO Global Influenza Programme. Today

LESSON 4.5 WORKBOOK. How do viruses adapt Antigenic shift and drift and the flu pandemic

A UNIQUE NETWORK OF EXPERTISE DEDICATED TO THE FIGHT AGAINST INFECTIOUS DISEASES

2.1 VIRUSES. 2.1 Learning Goals

Vaccines and Immunization research & development

OFFLU the joint OIE-FAO network of expertise on animal influenza

Bjoern Peters La Jolla Institute for Allergy and Immunology Buenos Aires, Oct 31, 2012

Proliferation Threats from Biotechnology: What is Dual-Use Research?

Opportunities in Pain Research with the NIH HEAL Initiative

the Office of Research Application Portal: Materials to submit:

Center for Biologics Evaluation and Research

PROMOTING AN EFFECTIVE MEDICAL COUNTERMEASURES ENTERPRISE

University of Pittsburgh Cancer Institute UPMC CancerCenter. Uma Chandran, MSIS, PhD /21/13

Following virus recombination and evolution

Indonesia s challenges and needs in improving national capabilities for disease surveillance, detection and diagnosis and public health systems:

PRECISION INSIGHTS. GPS Cancer. Molecular Insights You Can Rely On. Tumor-normal sequencing of DNA + RNA expression.

Image of Ebola viruses exiting host cells HUMAN VIRUSES & THE LIMITATION OF ANTIVIRAL DRUG AGENTS

U.S. Readiness for Pandemics

Image of Ebola viruses exiting host cells HUMAN VIRUSES & THE LIMITATION OF ANTIVIRAL DRUG AGENTS

Experimental Design for Immunologists

Unit 2: Lesson 2 Case Studies: Influenza and HIV LESSON QUESTIONS

TRANS-NIH PLAN FOR HIV RELATED RESEARCH

Pandemic Influenza Preparedness and Response

HVTN 505 Study HIV Vaccine Candidate Not Effective

Association of American Cancer Institutes

EU REFERENCE LABORATORIES FOR AVIAN INFLUENZA AND NEWCASTLE DISEASE

Overview: Chapter 19 Viruses: A Borrowed Life

Development of an Influenza Risk Assessment Tool

Pandemic Influenza Preparedness Framework. Sharing influenza viruses & access to vaccines and other benefits

New Opportunities in Cancer Research National Academy of Sciences Advancing Health Research in Poland and the United States December 3, 2009

Tool for Pandemic Influenza Risk Assessment (TIPRA) Presented by Gina Samaan Global Influenza Programme

Lecture 19 Evolution and human health

Patricia Fitzgerald-Bocarsly

NIAID Oversight of Clinical Research and Funding Opportunities

100 Years since the 1918 Spanish Flu Pandemic. Current Standards for Flu Pandemic Preparedness

A Bioinformatics Method for Identifying RNA Structures within Human Cells

INFLUENZA PANDEMIC CONTINUED FOCUS ON THE NATION S PLANNING AND PREPAREDNESS EFFORTS REMAINS ESSENTIAL

PREventing EMerging Pathogenic Threats (PREEMPT) Proposers Day

SEA/CD/154 Distribution : General. Avian Influenza in South-East Asia Region: Priority Areas for Research

2014 Towards an HIV Cure symposium Melbourne The Role of a Public-Private Partnership in HIV Cure

LESSON 4.4 WORKBOOK. How viruses make us sick: Viral Replication

genomics for systems biology / ISB2020 RNA sequencing (RNA-seq)

Submitted electronically to:

Planning for Pandemic Influenza

Innovations in nucleic acid amplification technologies. Automated platforms for NAT. Microfluidics Digital PCR Innovations in nucleic acid microarrays

Influenza; tracking an emerging pathogen by popularity of Google Searches

Summary of Data Dissemination Working Group. 22Jan2016

Developing the next generation of infection and immunity leaders. The Peter Doherty Institute for Infection and Immunity

Letter from the CEO. Dear Friends of IAVI,

Government Bioscience Grant (GBG) Report April 2015

Public Health Preparedness and Response Update

Cloudbreak. January Cidara Therapeutics

EVOLUTION: WHY DOES IT MATTER? What did evolution ever do for me?

Current strategies, initiatives and challenges to mitigate biorisk: Indonesia s experience

VIRUSES. Biology Applications Control. David R. Harper. Garland Science Taylor & Francis Group NEW YORK AND LONDON

EPIDEMICS AND PANDEMICS: PREDICTION, PREVENTION, CONTROL?

Fogarty Initiatives for Building Capacity in HIV/AIDS

1:15 2:00 KEYNOTE ADDRESS:

Getting the Most Out of Baculovirus. Linda Lua

Increasing Adult Immunization Rates in the US Through Data and Quality: A Roadmap

EC research and innovation strategy and actions

INFLUENZA-2 Avian Influenza

HS-LS4-4 Construct an explanation based on evidence for how natural selection leads to adaptation of populations.

2009 / 2010 H1N1 FAQs

Center for Global Health. CDC Global Health Saving Lives Overseas, Protecting Americans at Home

Viruses. Rotavirus (causes stomach flu) HIV virus

Lecture 2 Evolution in action: the HIV virus

Approaches to Pandemic Influenza Vaccine Preparedness

Meeting Minutes. Date: Wednesday, October 18, 2017 Time: 10:00 AM 12:00 PM

Current Vaccines: Progress & Challenges. Influenza Vaccine what are the challenges?

Cristina Cassetti, Ph.D.

Modeling the Antigenic Evolution of Influenza Viruses from Sequences

Enhancing Public Health Disease Surveillance, Detection, Diagnosis and Containment Capability in Nigeria.

Personalized medecine Biomarker

Set the stage: Genomics technology. Jos Kleinjans Dept of Toxicogenomics Maastricht University, the Netherlands

The EUA Process at CDC Michael W. Shaw, PhD

Advanced Lecture on One Health

Improving data for cervical cancer programming

Influenza. Influenza vaccines (WHO position paper) Weekly Epid. Record (2005, 80: ) 287

CE Unit. Viruses and Vaccines

The 100,000 Genomes Project

Human H5N1 and Pandemic Vaccines Practicalities of Production: A perspective from Industry

Combinatorial Vaccines for AIDS and other Infectious Diseases

Transcription:

Systems Biology and Animal Models: STRIDE Michael G Katze, Ph.D. presentation to Eighth Comparative Medicine Resource Directors Meeting May 10th, 2010

Questions What Pandemics Are We Currently Experiencing? A) HIV/AIDS B) Hepatitis C C) Swine Flu (H1N1) D) All of the above

Answer: D - All of the above

TRUE or FALSE? We do NOT have an AIDS Vaccine?

TRUE OR FALSE? Something Has To Change

KEY POINTS-DEFINITIONS TO REMEMBER What Is Systems Biology? What Is STRIDE? Prototype for Enabling Researchers Growth in Primate Genomics New Directions through Collaboration Information Overload POST GENOMICS AGE Paradigm Shift-New Vocabulary

Denis Noble: The Music of Life: Biology beyond the Genome Systems biology...is about putting together rather than taking apart, integration rather than reduction. It requires that we develop ways of thinking about integration that are as rigorous as our reductionist programmes, but different...it means changing our philosophy, in the full sense of the term Oxford University Press, (8 Jun 2006)

Systems Biology Paradigm

Current NHP SYSTEMS BIOLOGY Research Efforts NHP Models of Respiratory Disease 2009 Swine-origin H1N1 Influenza A Expression Analysis by Arrays Proteomics Analysis Agilent Collaboration NextGen Sequencing ABI Collaboration 1918 Pandemic Influenza vs. Highly Pathogenic Avian Influenza (HPAI) HPAI vs. reassortants of 1918 Pandemic Influenza (Battelle Infection Model) Filovirus Studies Correlates of protection in Ebola vaccine studies AIDS Pathogenesis and Vaccine Related Studies Natural Infections in AGM SVEU Vaccine Study Differences among DNA Vaccine Regimens NIDA P01 Proteomics Center opiate impact on pathogenesis in natural host HVTN STEP Profiling Vaccinees vs. Placebo, with impact of Ad5 Immunity In vitro HIV/SIV Systems Biology in controlled experimental context

How Can We Best Apply Systems Biology Approaches To Achieve Our Goal Of Improving Human Health?

Experience We Have Had Success Putting Together And Participating In Large Multidisciplinary Programs. Pacific Northwest Regional Center of Excellence NIDA Center for Functional Genomics Systems Biology Contract This experience and infrastructure can be leveraged by STRIDE

STRIDE- E IS FOR ENABLE STRIDE Represents A Prototype Center For Simultaneously Performing Basic Research And Enabling Collaboration Between A Diverse Group Of Scientists As Well As Giving Them Access To A Systems Biology Toolkit. www.thestridecenter.org Stimulus money Multi-center helping effort to fund that STRIDE continues through to grow Training Grants

Participating Institutions

Focus on Translational Research Taken from the ITHS website T0 is characterized by the identification of opportunities and approaches to health problems. T1 seeks to move basic discovery into a candidate health application. T2 assesses the value of application for health practice leading to the development of evidence-based guidelines. T3 attempts to move evidencebased guidelines into health practice, through delivery, dissemination, and diffusion research. T4 seeks to evaluate the real world health outcomes of population health practice.

New Community Context and Associations NCRR Informatics Initiative to integrate data and information on animal models Enable community to locate, identify, apply most useful animal models Anticipating WaNPRC and our Division as contributors to this effort Extensive knowledge of NHP models of viral diseases Extensive informatics infrastructure Advisory role in planning and resource prioritization Contributing role as generating models and linking to our genomics and other high-throughput data sets.

Collaborative Cross Mice Wide Range of Outcomes Percent Starting Mass 110 loss Weight Loss 105 100 95 90 Virus challenge 85 80 75 70 65 60 0 1 2 3 4 Days post challenge >400 genetically distinct strains

Acknowledgements - UNC Martin Ferris, Ralph Baric, Matt Frieman, Mark Heise, Fernando Pardo-Manuel de Villena

STRIDE RESOURCES

Current Collaborative Systems Biology Research Projects

New Collaborative Research Projects 1. Genomic profiling of pathogen-host interactions of oncogenic gammaherpesviruses in vivo. Timothy M. Rose, Ph.D. 2. Alterations of cellular metabolism by oncogenic herpesvirus. Michael Lagunoff, Ph.D. 3. BioGRID curation effort to systematically capture literature interactions and post-translational modifications for every human protein known to be either associated with or influenced by HIV-encoded factors. Mike Tyers, Ph.D. and Kara Dolinski, Ph.D. (Princeton University) Affiliated with LAMHDI

STRIDE Funding RC4 Recently Submitted

Leveraging STRIDE To Enhance Non- Human Primate Genomics Research

Growth in Primate Genomics Primate (2 (3 (4 nd rd th ) Seattle Genomics The Macaque International Workshop, Genome Conference January 2001 on on Primate Primate Genomics, Genomics, March April 2008 2010 2005 Consortium Publishes Attended In 2005, NHGRI by 90 participants initiates the that $20 included million dollar the Directors rhesus macaque of the eight National sequencing Attended Primate by project approximately Research Centers, 130 scientists Macaque NIH staff, from and Genome academia investigators and Attended by by more approximately than 190 scientists 170 scientists from diverse research working industry. on Members genomics of and the evolutionary nonhuman primate biology, models primate of research, backgrounds Introduction of a Bioinformatics This Workshop enables to refinement expose nonhuman and disease. genome sciences, AIDS, and infectious disease and biodefense primate Interest researchers in Bioinformatics to high-throughput Workshop improved so accuracy research much that tools of we macaquespecific and had making to cap communities This meeting, were the represented, first ever of its as kind, were was the productive NCRR Division and of registration sense of the data successful Comparative on Medicine multiple levels. and the First Office and of resources foremost, AIDS Research. as well as Caliber of Keynote speakers and attendees highlight it provided the success the of impetus Provided to NCRR a platform and NIH for roll-out critical to expand of newly data funding generated for comparative for research nonhuman previous conferences and increased interest in Primate Genomics in primate genomics. primate research tools including evolutionary macaque-specific genomics oligonucleotide microarrays.

Current Nonhuman Primate Genomics Efforts - STRIDE Reference RNA SEQ Transcriptome Project Born out of the 4 th International Primate Genomics Conference Collaboration between Industry (ILLUMINA-ABI (?)) and Academic Institutions Leveraging Next Generation Sequencing Technology Multiple tissues from ~12-18 nonhuman primate species of medical and evolutionary importance Data will be accessible by entire research community Genome 10K Project Steve O Brien et al (NCI) The Genome 10K project aims to assemble a genomic zoo a collection of DNA sequences representing the genomes of 10,000 vertebrate species How can we best leverage and intersect these two efforts? With help from STRIDE as a coordinating model, we will establish an international consortium on nonhuman primate genome sequencing

The World of Non- Human Primate Research Has Changed Forever

MOREOVER RUMOR HAS IT.. NHGRI Has Committed to Sequencing 30 Non- Human Primate Genomes?

IF NOT NIH THEN.?????

ALL OF THESE EFFORTS WILL BE GENERATING AN ENORMOUS AMOUNT OF DATA

Information Overload? New York Times April 2009

High-throughput Technologies are Generating an Unprecedented Amount of DATA How will researchers not currently involved with these technologies access and leverage this DATA? How will we ensure limited amounts of redundancy when generating genomic resources? How can we more quickly translate this DATA in to medical achievements? Role for BIRN? WITH TECHNOLOGY MOVING SO FAST, WE HAVE TO EVOLVE OUR PROCESS AND WAYS OF THINKING TO ACCOMMODATE AND TRANSLATE THE INFORMATION IN TO BETTER HUMAN HEALTH

The STRIDE Centers Goal Is To Enable Those Connections And Provide Access To The Appropriate Tools To achieve a truly systems level view utilizing highthroughput technologies, researchers from diverse backgrounds need to be connected and tools have to be put in place for effective interpretation and communication www.thestridecenter.org

Katze Lab Computational Biology Data Capture Data Access Statistical & Functional Analysis Integrative Analysis & Modeling Robust IT Infrastructure Scalable Computing Infrastructure LabKey Development Web Portal Development Enterprise Application Deployment Resolver / GeneData / GeneSpring Ingenuity IPA GeneGo MetaCore Spotfire DecisionSite Advanced Method Development NextGen Capability Host Response Compendium Multi-Omic Integrative Analysis Network Analysis

Robust IT Infrastructures Software Hardware

KEY POINTS-DEFINITIONS TO REMEMBER What Is Systems Biology? What Is STRIDE? Prototype for Enabling Researchers Growth in Primate Genomics New Directions through Collaboration Information Overload POST GENOMICS AGE Paradigm Shift-New Vocabulary

STRIDE-Solving The Puzzle Through Systems Biology Michael Katze honey@u.washington.edu www.viromics.washington.edu